Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Yingzhang Lin"'
Autor:
Irma Isordia-Salas, Fengling Li, Satya P. Kunapuli, Robert W. Colman, Robin A. Pixley, R. Balfour Sartor, Hemant K. Parekh, Yingzhang Lin, Anthony Stadnicki
Publikováno v:
Blood. 102:2835-2842
Crohn disease is immunologically mediated and characterized by intestinal and systemic chronic inflammation. In a rat model, injection of peptidoglycan-polysaccharide complexes into the intestinal wall induced chronic inflammation in Lewis but neithe
Publikováno v:
Biochemistry. 39:5104-5110
Previous investigations have shown that HK and its light chain bind heparin, preventing the enhancement of antithrombin inhibition of thrombin and potentiating the inhibition of plasma kallikrein by antithrombin. We found that both HK and HKa bound h
Publikováno v:
Blood. 95:543-550
We have demonstrated that high molecular weight kininogen (HK) binds specifically on endothelial cells to domain 2/3 of the urokinase receptor (uPAR). Inhibition by vitronectin suggests that kallikrein-cleaved HK (HKa) is antiadhesive. Plasma kallikr
Autor:
Robert W. Colman, Stuart L. Cooper, Abraham Majluf-Cruz, Mohammad M. Khan, Raul A. DeLa Cadena, Satya P. Kunapuli, Yingzhang Lin
Publikováno v:
American Journal of Physiology-Heart and Circulatory Physiology. 275:H145-H150
The binding of high-molecular-weight kininogen (HK) to neutrophils (polymorphonuclear leukocytes, PMN) is required for the stimulation of aggregation and degranulation by human plasma kallikrein as well as the displacement of fibrinogen from this cel
Publikováno v:
Blood. 90:690-697
A sequence of 31 amino acids (S565-K595) in domain 6 of the light chain of high molecular weight kininogen (HK) has previously been shown to be responsible for the binding of plasma prekallikrein (PK) or kallikrein. To find effective peptides that mi
Publikováno v:
Blood. 90:690-697
A sequence of 31 amino acids (S565-K595) in domain 6 of the light chain of high molecular weight kininogen (HK) has previously been shown to be responsible for the binding of plasma prekallikrein (PK) or kallikrein. To find effective peptides that mi
Autor:
Wuyi Yan, Keith R. McCrae, Yingzhang Lin, Robert B. Harris, Robert W. Colman, Shilpa S. Shenoy
Publikováno v:
Immunopharmacology. 36:193-200
HK31 (S565–K595) has previously been shown to encompass the binding domain for plasma prekallikrein (PK) within domain 6 of high molecular weight kininogen (HK). The complementary binding domain for HK within PK is mapped to PK56 (F56–G86), in th
Publikováno v:
Biochemistry. 35:12945-12949
HK31 (S565-K595) has previously been shown to encompass the binding domain for plasma prekallikrein (PK) within domain 6 of high molecular weight kininogen (HK). The complementary binding domain for HK within PK is mapped to PK56 (F56-G86), in the ap
Autor:
Yingzhang Lin, Ben M. Dunn, Raterman D, S. I. Foundling, Suvit Thaisrivongs, Lin Hong, Leelamanit W, Shah M, Lin X, Robert L. Heinrikson
Publikováno v:
Biochemistry. 34:1143-1152
Mutations of human immunodeficiency virus type 1 (HIV-1) protease at four positions, Val82, Asp30, Gly48, and Lys45 were analyzed for the resulting effects on kinetics and inhibition. In these mutants, Val82 was substituted separately by Asn, Glu, Al
Publikováno v:
Journal of thrombosis and haemostasis : JTH. 1(8)
Summary. We previously localized the heparin binding region on high molecular weight kininogen to domain 5 (D5) by quantifying the binding using surface plasmon resonance of D5 fused at its N-terminal to glutathione-S-transferase. We further examined